Stem cell transplantation results in AL amyloidosis
Reference . | Patients enrolled . | Deaths at SC collection . | Treated . | Deaths at SC infusion . | TRM . | Evaluable . | Responders . |
---|---|---|---|---|---|---|---|
Single-center clinical trials | |||||||
10 | 25 | 1 | 23 | 0 | 3 | 21 | 12 |
27 | 23 | 0 | 20 | 0 | 4 | 15 | 12 |
28 | 30 | 1 | 28 | 1 | 5 | 15 | 7 |
29 | 9 | 3 | 6 | 2 | 4 | 2 | 2 |
Total | 87 | 5 | 77 | 3 | 16 (21%) | 53 | 33 (62%) |
Multicenter clinical trials | |||||||
26 | 40 | 0 | 40 | 0 | 15 | 22 | 11 |
30 | 21 | 0 | 21 | 0 | 9 | 12 | 10 |
Total | 61 | 0 | 61 | 0 | 24 (39%) | 34 | 21 (62%) |
Reference . | Patients enrolled . | Deaths at SC collection . | Treated . | Deaths at SC infusion . | TRM . | Evaluable . | Responders . |
---|---|---|---|---|---|---|---|
Single-center clinical trials | |||||||
10 | 25 | 1 | 23 | 0 | 3 | 21 | 12 |
27 | 23 | 0 | 20 | 0 | 4 | 15 | 12 |
28 | 30 | 1 | 28 | 1 | 5 | 15 | 7 |
29 | 9 | 3 | 6 | 2 | 4 | 2 | 2 |
Total | 87 | 5 | 77 | 3 | 16 (21%) | 53 | 33 (62%) |
Multicenter clinical trials | |||||||
26 | 40 | 0 | 40 | 0 | 15 | 22 | 11 |
30 | 21 | 0 | 21 | 0 | 9 | 12 | 10 |
Total | 61 | 0 | 61 | 0 | 24 (39%) | 34 | 21 (62%) |
TRM indicates transplantation-related mortality.